A Case of T-cell Lymphoma Initially Presenting with Eosinophilia: Evaluation of Clinical and Pathological Findings

Öz

Objective: Hypereosinophilia is a rare clinical entity, often detected through routine hemograms. Its clinical significance stems from its association with myeloid/lymphoid neoplasms and the organ damage it causes. Case Report: In this case report, a patient who was being treated in the coronary intensive care unit for decompensated heart failure and whose routine complete blood count revealed eosinophilia underwent a bone marrow biopsy and a tru-cut biopsy of the involved lymph nodes. The results of both biopsies were consistent with T-cell lymphoma. The patient was placed on the CHOP protocol. Conclusion: Eosinophilia has a wide etiology spectrum, occurring in both hematological malignancies and benign conditions such as collagen tissue diseases. Therefore, patients with persistent eosinophilia on complete blood counts, even in the absence of clinical findings, should be referred to specialized centers.

Anahtar Kelimeler

• Hypereosinophilia
• lymphoma
• rhinitis
• vasculitis

Destekleyen Kurum

Samsun University

Etik Beyan

A written informed consent form was obtained from the patient.

Eozinofili ile Başlayan ve Sonrasında T Hücreli Lenfoma Tanısı Konan Bir Olgu: Klinik ve Patolojik Bulguların Değerlendirilmesi

Öz

Amaç: Hipereozinofili nadir görülen, çoğu zaman rutin hemogram tetkiklerinden tespit edilebilen klinik bir durumdur. Klinik olarak önemi miyeloid ve lenfoid neoplazmlar ile olan ilişkisi ve neden olduğu organ hasarıdır. Olgu Sunumu: Bu olgu sunumunda dekompanse kalp yetmezliği sebebiyle koroner yoğun bakım ünitesinde tedavi gören ve rutin tam kan sayımlarında eozinofili saptanan hastaya kemik iliği biyopsisi yapıldı ve patolojik lenf nodlarından tru-cut biyopsi uygulandı. Her iki biyopsinin sonucu da T hücreli lenfoma ile uyumlu geldi. Hastaya CHOP (Siklofosfamid, Doksorubisin, Vinkristin, Prednizon) protokolü uygulandı. Sonuç: Eozinofili hem hematolojik malignitelere hem de kollajen doku hastalıkları gibi benign sebeplerle ortaya çıkabilen geniş bir etyolojik yelpazeye sahiptir. Bu sebeple klinik bulguları olmasa bile tam kan sayımında sebat eden eozinofiliye sahip olan hastalar bu konuda uzmanlaşmış merkezlere sevk edilmelidir.

Anahtar Kelimeler

• Hipereozinofili
• lenfoma
• rinit
• vaskülit

Destekleyen Kurum

Samsun Üniversitesi

Etik Beyan

Yazılı bilgilendirilmiş onam formu hastaya imzalatılmıştır.

Kaynakça

1. Referans 1.Tefferi A, Gotlib J, Pardanani A.Hypereosinophilic Syndrome and Clonal Eosinophilia: Point-of-Care Diagnostic Algorithm and Treatment Update. Mayo Clin Proc 2010; 85: 158 - 164.
2. Referans 2. Tefferi A, Patnaik MM, Pardanani A. Eosinophilia: Secondary, Clonal and İdiopathic. Br J Haematol. 2006 Jun;133(5):468-92.
3. Referans 3. Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Bjornson BH. NIH Conference. The İdiopathic Hypereosinophilic Syndrome. Clinical, Pathophysiologic, and Therapeutic Considerations. Ann Intern Med. 1982 Jul;97(1):78-92.
4. Referans 4. Gotlib J, Cools J, Malone JM 3rd, Schrier SL, Gilliland DG, Coutré SE. The FIP1L1-PDGFR Alpha Fusion Tyrosine Kinase in Hypereosinophilic Syndrome and Chronic Eosinophilic Leukemia: İmplications for Diagnosis, Classification, and Management. Blood. 2004; 15;103(8):2879-91.
5. Referans 5. Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, et al. The 5th Edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022; 36(7):1720-1748.
6. ,Referans 6. Ackerman SJ, Butterfield JH. Eosinophilia, Eosinophil-associated Disease, Khronic Eosinophilic Leukemia, and the Hypereosinophilic Syndromes. In: Hoffman R, Benz EJ, Shattil S, et al., eds. Hematology: Basic Principles and Practice. 4th ed. Philadelphia: Elsevier Churchill Livingstone; 2005. p. 763–86.
7. Referans 7. Valent P, Klion AD, Horny HP, Roufosse F, Gotlib J, Weller PF, et al. Contemporary Consensus Proposal on Criteria and Classification of Eosinophilic Disorders and Related Syndromes. J Allergy Clin Immunol. 2012; 130(3):607-612.e9
8. Referans 8. Mankad R, Bonnichsen C, Mankad S. Hypereosinophilic Syndrome: Cardiac Diagnosis and Management. Heart. 2016; 102(2):100-6.

9. Referans 9. Crane MM, Chang CM, Kobayashi MG, Weller PF. Incidence of Myeloproliferative Hypereosinophilic Syndrome in the United States and an Estimate of all Hypereosinophilic Hyndrome İncidence. J Allergy Clin Immunol. 2010; 126(1):179-81.
10. Referans 10. Lefebvre C, Bletry O, Degoulet P, Guillevin L, Bentata-Pessayre M, Le Thi Huong Du, et al. Facteurs Pronostiques du Syndrome Hyperéosinophilique. Etude de 40 Observations [Prognostic Factors of Hypereosinophilic Syndrome. Study of 40 Cases]. Ann Med Interne (Paris). 1989;140(4):253-7.
11. Referans 11. Sun RR, Chen TZ, Meng M. Hypereosinophilic Syndrome Presenting as Acute İschemic Stroke, Myocardial İnfarction, and Arterial İnvolvement: A Case Report. World J Clin Cases. 2022 Apr 16;10(11):3547-3552.
12. Referans 12. Ruzycki S, Miller RJ, Harrison T. Eosinophilia in a Man With Suspected Acute Coronary Syndrome. JAMA Intern Med. 2016 Nov 1;176(11):1711-1713.
13. Referans 13. Engelmann MG, Kolbe T, Faul C, Steinbeck G. Hypereosinophilic Syndrome Associated With Heterozygous Factor V Gene Mutation: an Unusual Combination Resulting in an Acute Coronary Syndrome and Recurrent Cerebral Stroke-a Case Report. Angiology. 2004; 55(2):221-5.
14. Referans 14. Gurgun A, Tuluce K, Tuluce SY, Gurgun C, Bayraktaroglu S, Tombuloglu M, ve ark. Hypereosinophilic Syndrome Presenting With Large Left Ventricular Apical Thrombus and Pulmonary Embolism. Echocardiography. 2011; 28(9):E180-2.
15. Referans 15. Goldberg L, Mekel J, Chita G. Acute myocarditis in a Patient With Eosinophilia and Pulmonary İnfiltrates. Cardiovasc J S Afr. 2002; 13(1):29-34.
16. Referans 16. International Non-Hodgkin's Lymphoma Prognostic Factors Project. A Predictive Model for Aggressive Non-Hodgkin's Lymphoma. N Engl J Med. 1993; 30;329(14):987-94.
17. Referans 17.Ahern K, Gilmore ES, Poligone B. Pruritus in Cutaneous T-cell Lymphoma: a Review. J Am Acad Dermatol. 2012; 67(4):760-8.
18. Referans 18. Von Wasielewski R, Seth S, Franklin J, Fischer R, Hübner K, Hansmann ML, et al. Tissue Eosinophilia Correlates Strongly With Poor Prognosis in Nodular Sclerosing Hodgkin's Disease, Allowing for Known Prognostic Factors. Blood. 2000; 15;95(4):1207-13.